Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update - New Market Report
Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services such as rosetta cancer origin test, resetta lung cancer test, rosetta kidney cancer test and rosetta mesothelioma test. RGL product pipeline includes tests such as thyroid neoplasia, oncology project, kidney rejection, Alzheimer's disease, therapeutics and CMV. The company has distribution network in Australia, New Zealand, Singapore, Canada, Greece, India, Saudi Arabia, Qatar, the UAE, Israel...
View full press release